- Home
- GOGL vs BCRX Comparison
GOGL vs BCRX Comparison
Compare GOGL & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOGL
- BCRX
- Stock Information
- Founded
- GOGL N/A
- BCRX 1986
- Country
- GOGL Bermuda
- BCRX United States
- Employees
- GOGL N/A
- BCRX N/A
- Industry
- GOGL Marine Transportation
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GOGL Consumer Discretionary
- BCRX Health Care
- Exchange
- GOGL Nasdaq
- BCRX Nasdaq
- Market Cap
- GOGL 1.4B
- BCRX 1.7B
- IPO Year
- GOGL 1997
- BCRX 1994
- Fundamental
- Price
- GOGL $7.71
- BCRX $9.97
- Analyst Decision
- GOGL Hold
- BCRX Buy
- Analyst Count
- GOGL 2
- BCRX 8
- Target Price
- GOGL $10.25
- BCRX $16.75
- AVG Volume (30 Days)
- GOGL 2.2M
- BCRX 3.6M
- Earning Date
- GOGL 05-21-2025
- BCRX 08-04-2025
- Dividend Yield
- GOGL 10.22%
- BCRX N/A
- EPS Growth
- GOGL N/A
- BCRX N/A
- EPS
- GOGL 0.57
- BCRX N/A
- Revenue
- GOGL $863,612,000.00
- BCRX $503,485,000.00
- Revenue This Year
- GOGL N/A
- BCRX $39.04
- Revenue Next Year
- GOGL $11.09
- BCRX $13.26
- P/E Ratio
- GOGL $13.76
- BCRX N/A
- Revenue Growth
- GOGL N/A
- BCRX 41.67
- 52 Week Low
- GOGL $6.27
- BCRX $5.92
- 52 Week High
- GOGL $14.29
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- GOGL 50.90
- BCRX 43.54
- Support Level
- GOGL $7.79
- BCRX $9.84
- Resistance Level
- GOGL $7.98
- BCRX $10.47
- Average True Range (ATR)
- GOGL 0.15
- BCRX 0.34
- MACD
- GOGL 0.01
- BCRX -0.19
- Stochastic Oscillator
- GOGL 55.88
- BCRX 8.16
About GOGL Golden Ocean Group Limited
Golden Ocean Group Ltd is a Bermuda-based dry bulk shipping company. Its business involves the transportation of dry bulk cargo including ores, coal, grains and fertilizers through its fleet of owned and chartered vessels, bareboat vessels, commercial management vessels and new buildings are chartered-out on fixed rate time charters and index-linked time charter contracts. The Company's single operating segment derives revenue from transporting dry bulk cargoes and chartering vessels to customers on time charter or voyage charter contracts.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.